New York, NY - April 27, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, specializing in sector research, issues a trading alert for Jazz Pharmaceuticals plc (NasdaqGS: JAZZ). The stock is trading at $52.69, up $ 7.49(16.58%)as of 1:54PM EDT on over 3 Million shares.
Yesterday Jazz Pharmaceuticals reported it has agreed to acquire
EUSA Pharma, a privately-held, specialty pharmaceutical company with
headquarters in the United States and United Kingdom, for $650 million
in cash and a potential $50 million milestone payable in cash based upon
its lead product, Erwinaze(TM) (asparaginase Erwinia chrysanthemi),
achieving a specified U.S. net sales target in 2013.
Jazz Pharmaceuticals plc is a specialty biopharmaceutical company
focused on improving patients' lives by identifying, developing and
commercializing products that address unmet medical needs. The company
has a diverse portfolio of products in the areas of narcolepsy, pain,
psychiatry and women's health. The company's marketed products in these
areas include: Xyrem® (sodium oxybate), Prialt® (ziconotide intrathecal
infusion), FazaClo® (clozapine USP) HD and LD, Luvox CR® (fluvoxamine
maleate) and Elestrin® (estradiol gel 0.06%).
Research biotech stocks at Investorideas.com with the global stock
directory of biotech and pharma stocks on the TSX, OTC, NASDAQ, NYSE and
other leading exchanges http://www.investorideas.com/ BIS/Stock_List.asp
Sign Up: http://www.investorideas.com/Resources/ Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks Join: http://www.investorideas.com/ membership/
InvestorIdeas.com is a leader in investor stock research by sector.
Sectors we cover include; water and renewable energy stocks, biotech
stocks, mining and gold stocks, energy stocks, natural gas stocks, tech
(includes cloud and social networking), defense stocks, nanotech,
China stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our
sites should be construed as an offer or solicitation to buy or sell
products or securities. We attempt to research thoroughly, but we offer
no guarantees as to the accuracy of information presented. All
Information relating to featured companies is sourced from public
documents and/ or the company and is not the opinion of our web sites.
This site is currently compensated by featured companies, news
submissions and online advertising.
From time to time Investorideas.com buys shares in companies it features. As a policy, Investorideas.com does not short stocks
Source - www.Investorideas.com